Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct;30(10):463-470.
doi: 10.1089/apc.2016.0165.

Invasive Pneumococcal Disease Among HIV-Infected and HIV-Uninfected Adults in a Large Integrated Healthcare System

Julia L Marcus  1 , Roger Baxter  1 , Wendy A Leyden  1 , Dharushana Muthulingam  2 , Arnold Yee  1 , Michael A Horberg  3 , Daniel B Klein  4 , William J Towner  5 , Chun R Chao  6 , Charles P Quesenberry Jr  1 , Michael J Silverberg  1
Affiliations

Invasive Pneumococcal Disease Among HIV-Infected and HIV-Uninfected Adults in a Large Integrated Healthcare System

Julia L Marcus et al. AIDS Patient Care STDS. 2016 Oct.

Abstract

It is unclear whether HIV-infected individuals remain at higher risk of invasive pneumococcal disease (IPD) compared with HIV-uninfected individuals. We conducted a cohort study of HIV-infected and demographically matched HIV-uninfected adults within Kaiser Permanente Northern California during the period 1996-2011. We used Poisson models to obtain rate ratios (RRs) for incident IPD associated with HIV infection and other risk factors. Among 13,079 HIV-infected and 137,643 HIV-uninfected adults, the IPD rate per 100,000 person-years was 160 (n = 109 events) for HIV-infected and 8 (n = 75 events) for HIV-uninfected subjects, with an adjusted RR of 13.0 [95% confidence interval (CI): 9.1-18.7]. For HIV-infected individuals, IPD incidence per 100,000 person-years decreased by 71% during study follow-up, from 305 in 1996-1999 to 88 in 2010-2011 (p < 0.001), with an adjusted RR of 6.6 (95% CI: 2.7-16.1) compared with HIV-uninfected subjects in 2010-2011. Risk factors for IPD among HIV-infected individuals included black compared with white race/ethnicity, smoking, cancer, and higher HIV RNA levels. The 23-valent pneumococcal polysaccharide vaccination was not associated with a reduced risk of IPD in HIV-infected or HIV-uninfected individuals. Among HIV-infected IPD cases, the most common serotype was 19A (33%), and 59% of serotypes were covered by the 13-valent pneumococcal conjugate vaccine (PCV13). Despite a dramatic decline in IPD incidence for HIV-infected adults since 1996, IPD rates were nearly sevenfold higher compared with HIV-uninfected adults in recent years, even after adjustment for risk factors. Timely antiretroviral therapy initiation, risk reduction strategies, and recent guidelines recommending PCV13 use may further reduce IPD incidence among HIV patients.

Keywords: Streptococcus pneumonia infections; acquired immunodeficiency syndrome (AIDS); human immunodeficiency virus (HIV); pneumococcal vaccines; serotype.

PubMed Disclaimer

Conflict of interest statement

W.A.L. received research grant support from Pfizer. J.L.M. received research grant support from Merck. M.A.H., C.P.Q., M.J.S., and C.R.C. received research grant support from Pfizer and Merck. W.J.T. received research grant support from Pfizer, Merck, Gilead, Bristol-Myers Squibb, ViiV Healthcare, and Vertex. All other authors report no conflicts of interest.

Figures

<b>FIG. 1.</b>
FIG. 1.
Unadjusted rates of IPD among HIV-infected and HIV-uninfected adults. Changes over time were statistically significant for HIV-infected (p < 0.001), but not HIV-uninfected, individuals (p = 0.53). IPD, invasive pneumococcal disease.
See this image and copyright information in PMC

References

    1. Janoff EN, Breiman RF, Daley CL, Hopewell PC. Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann Intern Med 1992;117:314–324 - PubMed
    1. Hirschtick RE, Glassroth J, Jordan MC, et al. . Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med 1995;333:845–851 - PubMed
    1. Barry PM, Zetola N, Keruly JC, Moore RD, Gebo KA, Lucas GM. Invasive pneumococcal disease in a cohort of HIV-infected adults: Incidence and risk factors, 1990–2003. AIDS 2006;20:437–444 - PubMed
    1. Harboe ZB, Larsen MV, Ladelund S, et al. . Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: Persistent high risk among HIV-infected injecting drug users. Clin Infect Dis 2014;59:1168–1176 - PubMed
    1. Heffernan RT, Barrett NL, Gallagher KM, et al. . Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995–2000. J Infect Dis 2005;191:2038–2045 - PubMed

MeSH terms

Substances